pageInfo({
    time : "1261283837589"
  
	    , page : null
	  
	    , url : null
	  
	    , instrument : null
	  
	    , article : {
	        storyId : "USN3035017120080531"
	        , headline : "REFILE-Erbitux adds 5 weeks to lung cancer survival-study"
	        , keywords : "[United States of America, Biotechnology, Chemicals, Pharmaceuticals (sub-industry), Healthcare, Pharmaceuticals and biotechnology, Pharmaceuticals - generic and speciality, Germany, Western Europe, Europe, Pharmaceuticals - diversified, Central and Eastern Europe, Economic news, EC, business/financial pages]"
	        , tickers : "[BMY.N, us;MERP, us;IMCL, us;DNA, us;BMY, mx;BMY, MRCG.DE, DNA.N, de;MRKX, de;MRK, de;BRMX, de;BRMS, de;BRMF, de;BRM, ch;MRK, us;MRK, IMCL.O]"
	    }
	    , channel : {
	        id : "113"
	        , name : "marketsNews"
	        , title : "Market News"
	    }})